Transient isolated right ventricular hypertrophy is rarely encountered in neonates. We describe a term neonate in whom right ventricular hypertrophy was detected in the first postnatal day by echocardiography. There are several reasons that cause transient isolated right ventricular hypertrophy such as gestational diabetes, mother's dietary patterns, and certain drugs.
Introduction
Transient right ventricular hypertrophy is a rare disease of neonates. Metabolic diseases, maternal diabetes mellitus, non-stereoid anti-inflammatory drug use during pregnancy, and dexamethasone use for bronchopulmonary dysplasia in premature infants can induce transient right ventricular hypertrophy [1] [2] [3] [4] [5] [6] [7] . Mother's intake of foods with high polyphenol content is also suspected to be responsible for development of right ventricular hypertrophy [1, 8] . Prenatal causes apart from maternal diabetes and metabolic diseases are reported to cause fetal distress by leading ductus arteriosus construction which results in pulmonary hypertension and right ventricular hypertrophy [1] . Present case was found interesting in terms of detection of right ventricular hypertrophy in first postnatal day in echocardiographic examination and observation of closed ductus arteriosus at first examination.
Case Report
A newborn female patient was admitted to our clinic because of cyanosis. She was born as the first child of non consanguineous healthy parents, via cesarean section due to perinatal stress. Pregnancy was uneventful and family history was unremarkable. There was no history of any medication and gestational diabetes mellitus. Oral glucose tolerance test was normal. Birth weight was 3345 g, and APGAR score at 1 and 5, minute was 6 and 7 respectively. Oxygen saturation on room air was 69%, and was rised to 83% with oxygen supplement. A grade II systolic murmur was present in the tricuspid focus. Transthorasic echocardiographic examination performed at postnatal 6 hour revealed massive hypertrophy in the right ventricle (right ventricular anterior wall thickness was 12 mm, interventricular to hypertrophy. To increase right ventricular compliance propranolol was commenced. An oxygen saturation ranged between 83-85% was achieved with the supplementation of 40% oxygen. Saturation values rose up to 90% as of day three and oxygen supplement weaned. The case was discharged oxygen-free and breastfed by the mother on the seventh day. On the day 10 normal saturation values observed and in control echocardiographic examination right ventricular anterior wall thickness measured as 8 mm, while interventricular septum was 6 mm and on the day 40 it was 5.3 and 5.8 mm respectively (Figure 2 ). Thyroid function tests, Tandem-Mass analysis, and enzyme level for the Pompe's disease were normal.
Discussion
Congenital heart diseases such as, pulmonary stenosis, tetralogy of Fallot, and truncus arteriosus may lead to right ventricular hypertrophy [1] . Other causes of right ventricular hypertrophy are metabolic diseases, maternal diabetes, and early closure of ductus arteriozus [1, 3] . Transient right ventricular hypertrophy was associated with acute perinatal stress [1, 3, 9] . It is well known that mother's intake of aspirin, glucocorticoids, non-stereoid antiinflammatory drug may cause early closure of ductus arteriosus in neonates. Early closure of ductus arteriosus is suggested to be related with the dietary patterns [1, 8] . Vaillant reports 3 hypotheses that can cause right ventricular hypertrophy: a) Mechanic adaptation hypothesis caused by increased pressure or volume overload due to perinatal stress, b) Metabolic hypothesis caused by catecholamine increase, and c) Calcium based ionic derivation hypothesis [3] . Transient right ventricular hypertrophy in the early neonatal phase is an important observation, because it demonstrates that in contrast to adults RVH is still reversible in the perinatal period, when the fetal circulation is significantly altered after birth when the lungs become involved in gas exchange: [I] This observation suggests that (pulmonary hypertensioninduced) RVH can be treated effectively in the early neonatal period, in which the immature lung and developing heart are probably more susceptible to effective treatment. This observation confirms data found in neonatal rats, in which directly after birth the right ventricular free wall is relatively thick compared to the left ventricular free wall and hyperoxia-induced RVH can be completely reversed by pharmacological intervention in the early neonatal period.
In present case echocardiography was excluded structural causes. Spontaneous regression, normal metabolic screening test results and normal enzyme analysis excluded the metabolic causes and Pompe's disease. Normal oral glucose tolerance test during pregnancy, normal birth weight, and absence of postnatal hypoglycemia were excluded gestational diabetes mellitus.
To our knowledge present case is the first case in which right ventricular hypertrophy was detected on the first postnatal day. Two cases reported by Tomar et al. [9] were diganosed on the 3. postnatal day, three cases reported by Vaillant et al. [3] were diagnosed between the days 2-7, and Karatas et al. [1] reported a case diagnosed on the third day. In general, cardiac hypertrophy is known to be developed during postnatal period [3] . Our case was delivered via cesarean section due to perinatal stress, and presence of the pronounced hypertrophy 6 hours after delivery suggested antenatal development of the process. Closed ductus arteriosus confirmed the role of early closure of ductus arteriosus on the etiology of right ventricular hypertrophy [10] [11] [12] . It is known that cardiac hypertrophy due to hypoxic injury, as similar in diabetic mother's babies, is a benign process and regresses within as 1-5 months spontaneously [3, 9] . Effect of propranolol on the regression of hypertrophy and its use as a therapeutic option, as we commenced to repair the right ventricular compliance in our case, still remains controversial.
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